Top Markets
#1 Tutorial Tutorial +45.75%
#2 Siacoin Siacoin +28.41%
#3 Official Trump Official Trump +20.74%
#4 Unit Pump Unit Pump +20.47%
#5 Pump.fun Pump.fun +20.47%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +20.32%
#7 EXOD EXOD +18.93%
#8 MowCat MowCat +17.72%
#9 Stacks Stacks +15.29%
#10 Mubarak Mubarak +14.29%
Coin of the day
Tutorial Tutorial
Settings
Language
ENGLISH
Currency
USD
Theme
Eastwood Bio-Medical Canada Inc. Eastwood Bio-Medical Canada Inc.

Eastwood Bio-Medical Canada Inc.

EBM
Rank in Stocks #22612
Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is... Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is a company focused on the worldwide marketing and distribution of natural health products. Operating under the Eleotin brand, their offerings are available across Canada, the United States, and Asian regions. The firm's core mission is to deliver natural remedies for prevalent metabolic disorders, including issues with blood glucose regulation, hypertension, and obesity. Their extensive portfolio of licensed Eleotin products addresses diverse health requirements. For individuals experiencing spleen deficiency, appetite loss, or fatigue, Eleotin A 700 provides support. Eleotin AL88 serves as a laxative, while Eleotin Cal20 aids in the maintenance of healthy bones and teeth. Eleotin V3D is formulated for the development and upkeep of strong bones, teeth, and overall well-being. To support cardiovascular health, they offer Eleotin G2000. Eleotin H55 is designed to act as a sedative and alleviate tension, and Eleotin Zn330 is vital for tissue formation and metabolic processes. Furthermore, their product line includes Eleotin Bentley, which promotes balanced glucose levels, and Eleotin LBM, intended for hypertension relief.
Share Price
$1.25
Last synced: 2026-08-21
Market Cap
$85.95M
Change (1 day)
-12.37%
Change (1 year)
475.37%
Country
CA
Trade Eastwood Bio-Medical Canada Inc. (EBM)

Category

Healthcare
P/E ratio for Eastwood Bio-Medical Canada Inc. (EBM)
P/E ratio as of 2026 TTM: 0
According to Eastwood Bio-Medical Canada Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Eastwood Bio-Medical Canada Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Sysco Corporation Sysco Corporation
Sysco Corporation
SYY.US
 22.61 -
US
US Foods Holding Corp. US Foods Holding Corp.
US Foods Holding Corp.
USFD.US
 33.01 -
US
Performance Food Group Co Performance Food Group Co
Performance Food Group Co
PFGC.US
 46.63 -
US
The Chefs' Warehouse, Inc. The Chefs' Warehouse, Inc.
The Chefs' Warehouse, Inc.
CHEF.US
 45.83 -
US
Atacadão S.A. Atacadão S.A.
Atacadão S.A.
CRFB3.SA
 10.22 -
BR
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.